Form 4 for BSX Boston Scientific
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0001225208-25-001195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-04 | 2025-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $24.81 | +17.3K | 12.5K | New | +$429.5K |
| DM | 2025-02-04 | 2025-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | S - Sale+OE | $101.80 | -17.3K | 5,502 | -76% | -$1.76M |
| DM | 2025-02-04 | 2025-02-03 | BSX | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | M - OptEx | $0.00 | -17.3K | 3,027 | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 3,176 | $22.71 | 21,806 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-03 | M | A | 1,009 | $17.26 | 22,815 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-03 | S | D | 8,508 | $101.45 | 14,307 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.895 to $101.86, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-02-03 | M | A | 6,176 | $24.55 | 18,630 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-03 | M | A | 6,952 | $27.09 | 12,454 | D | — | — | |
| 6 | Common | Common Stock | 2025-02-03 | S | D | 8,805 | $102.14 | 5,502 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 6,952 | $0.00 | 20,856 | D | $27.09 · — to 2028-02-15 | 6,952 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 6,176 | $0.00 | 18,527 | D | $24.55 · — to 2027-02-28 | 6,176 Common Stock | (F7) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 3,176 | $0.00 | 9,530 | D | $22.71 · — to 2026-06-01 | 3,176 Common Stock | (F8) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 1,009 | $0.00 | 3,027 | D | $17.26 · — to 2026-02-22 | 1,009 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |